Sign in

CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company

TriSalus Life Sciences, Inc.

Sign in to watch
Ticker
TLSI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853009869
Phone
415 336 8917
Business address
6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
Former names
MedTech Acquisition Corp, MedTech Acquisition Corporation

Securities

  • TLSI Common Stock Nasdaq
  • TLSIW Warrant Nasdaq
  1. 4 Grant or award Chief Financial Officer acquired 14,762 shares (grant or award)
  2. 4 Grant or award CHIEF REGULATORY OFFICER acquired 14,481 shares (grant or award)
  3. 4 Grant or award CHIEF OF RESEARCH acquired 11,450 shares (grant or award)
  4. 4 Grant or award Chief Commercial Officer acquired 7,644 shares (grant or award)
  5. 4 Grant or award CEO AND PRESIDENT acquired 21,089 shares (grant or award)
  6. 4 Grant or award Chief of Clinical Operations acquired 5,272 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy Chief Financial Officer bought 6,000 shares at $5.65 ($33,900)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy CEO AND PRESIDENT bought 10,040 shares at an average $5.15 ($51,754)
  16. 4 Open-market buy CEO AND PRESIDENT bought 9,542 shares at an average $5.27 ($50,303)
  17. 4 Open-market buy Chief Manuf, Strategy&Bus Dev. bought 30,000 shares at an average $5.24 ($157,200)
  18. 4 Grant or award CHIEF OF RESEARCH acquired 10,625 shares (grant or award)
  19. 4 Open-market buy Chief Financial Officer bought 24,000 shares at $5.40 ($129,600)
  20. 4 Grant or award Chief of COMMERC. OPERATIONS acquired 10,625 shares (grant or award)

Page 4 of 9 · 163 filings